grant

Investigations into supraphysiologic T cell receptors and T cell agonists. [ 2012 - 2015 ]

Also known as: Modifying immune receptors for therapeutics and vaccines against infectious disease and cancer.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1031652]

Researchers: A/Pr John Miles (Principal investigator)

Brief description T cells are critical in controlling infection and important for the natural eradication of cancer. Through shape recognition, T cells identify dangerous antigens via the surface-bound T cell receptor (TCR). Using new technologies this project aims to "tune up" the strength of this molecular interaction and create a new generation of high affinity TCR and antigens for use as therapeutic and prophylactic drugs in the battle against infectious disease and cancer.

Funding Amount $AUD 408,388.01

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]
ACN 633 798 857